This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Bass SB , D'Avanzo P , Alhajji M , Ventriglia N , Trainor A , Maurer L , Eisenberg R , Martinez O
Exploring the Engagement of Racial and Ethnic Minorities in HIV Treatment and Vaccine Clinical Trials: A Scoping Review of Literature and Implications for Future Research
AIDS Patient Care STDS. 2020 Sep;34(9) :399-416
PMID: 32931317 URL: https://www.ncbi.nlm.nih.gov/pubmed/32931317
AbstractHIV disproportionately impacts US racial and ethnic minorities but they participate in treatment and vaccine clinical trials at a lower rate than whites. To summarize barriers and facilitators to this participation we conducted a scoping review of the literature guided by the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Studies published from January 2007 and September 2019 were reviewed. Thirty-one articles were identified from an initial pool of 325 records using three coders. All records were then assessed for barriers and facilitators and summarized. Results indicate that while racial and ethnic minority participation in these trials has increased over the past 10 years, rates still do not proportionately reflect their burden of HIV infection. While many of the barriers mirror those found in other disease clinical trials (e.g., cancer), HIV stigma is a unique and important barrier to participating in HIV clinical trials. Recommendations to improve recruitment and retention of racial and ethnic minorities include training health care providers on the importance of recruiting diverse participants, creating interdisciplinary research teams that better represent who is being recruited, and providing culturally competent trial designs. Despite the knowledge of how to better recruit racial and ethnic minorities, few interventions have been documented using these strategies. Based on the findings of this review, we recommend that future clinical trials engage community stakeholders in all stages of the research process through community-based participatory research approaches and promote culturally and linguistically appropriate recruitment and retention strategies for marginalized populations overly impacted by HIV.
Notes1557-7449 Bass, Sarah Bauerle D'Avanzo, Paul Alhajji, Mohammed Ventriglia, Nicole Trainor, Aurora Maurer, Laurie Eisenberg, Rebecca Martinez, Omar Journal Article United States AIDS Patient Care STDS. 2020 Sep;34(9):399-416. doi: 10.1089/apc.2020.0008.